Paper Details
- Home
- Paper Details
A prospective study of mifepristone and unlimited dosing of sublingual misoprostol for termination of second-trimester pregnancy in Uzbekistan and Ukraine.
Author: KurbanbekovaDilfuza, MaystrukGalyna, PlataisIngrida, TsereteliTamar, WinikoffBeverly
Original Abstract of the Article :
INTRODUCTION: We aimed to assess the feasibility and acceptability of a second-trimester medical abortion regimen using mifepristone and sublingual misoprostol with no maximum number of misoprostol doses in Uzbekistan and Ukraine. METHODS: This prospective open-label study enrolled 306 women with p...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1136/bmjsrh-2018-200167
データ提供：米国国立医学図書館（NLM）
Second-Trimester Medical Abortion: A Camel's Journey Through the Desert of Reproductive Health
Medical abortion is a safe and effective option for terminating pregnancy, but its use in the second trimester has been more limited. This study investigates the feasibility and acceptability of a second-trimester medical abortion regimen using mifepristone and sublingual misoprostol in Uzbekistan and Ukraine. The researchers enrolled 306 women with pregnancies of 13-22 weeks, assessing the effectiveness, safety, and patient satisfaction of this regimen.
Mifepristone and Misoprostol: A Promising Approach to Second-Trimester Medical Abortion
The study demonstrates that the combination of mifepristone and sublingual misoprostol is effective and acceptable for second-trimester medical abortion, with a high rate of complete uterine evacuation without surgical intervention. This finding suggests that this regimen could expand access to safe and effective medical abortion services for women seeking to terminate pregnancies in the second trimester.
Navigating the Desert of Reproductive Choices: A Camel's Perspective on Medical Abortion
This research provides valuable insights into the safety and effectiveness of second-trimester medical abortion, highlighting the potential of this approach to expand access to safe and effective reproductive healthcare for women. By offering a non-surgical option for terminating pregnancies in the second trimester, this regimen could empower women to make informed decisions about their reproductive health.
Dr. Camel's Conclusion
This study offers a promising approach to second-trimester medical abortion, providing evidence for the safety, effectiveness, and acceptability of mifepristone and sublingual misoprostol in terminating pregnancies in this gestational period. By expanding access to safe and effective medical abortion services, this approach could empower women to make informed choices about their reproductive health.
Date :
- Date Completed n.d.
- Date Revised 2022-04-08
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.